Cartalax
Joint health
Cartilage bioregulator — for joints that ache before they fail.
Tripeptide bioregulator for cartilage and connective tissue. Aims to restore chondrocyte gene expression rather than simply mask joint pain.
- Early osteoarthritis
- Athletes with chronic joint wear
- Post injury cartilage support
Educational only · Not a vendor claim
Tripeptide bioregulator restoring chondrocyte gene expression in cartilage and connective tissue.
- Cartilage maintenance
- Joint comfort
- Post injury support
- Reduced joint stiffness
- Better mobility
- Targets root joint biology
- Pulsed dosing
- Pairs with BPC-157
- Effects gradual
- Best as preventive
- Rare local soreness
Educational summary · Not medical advice · Discuss with a qualified clinician
Typical timeline
General pattern for the Bioregulator category. Individual response varies.
- Days 1–10No acute effects. This class works at the gene expression level — subtle by design.
- Days 10–20Organ-specific improvements accumulate. Bloodwork often reflects the change more than symptoms do.
- Post-cycleBenefits persist 2–4 months. Standard cadence is 20–30 days on, then a 2-month break, 2–3 cycles per year.
The reconstitution math
- 1Reconstitute the 20 mg vial with 2 mL of bacteriostatic water. Tilt — don't shake.
- 2Concentration becomes 10,000 mcg/mL (10 mg/mL).
- 3For a 2 mg dose, draw 0.200 mL — that's 20 units on a 1 mL insulin syringe.
- 4One vial gives you approximately 10 doses.
Reminder: 100 units on an insulin syringe = 1 mL. Always start at half the listed dose for the first week and rotate injection sites between arms, legs, abdomen, and glutes.
Sign in to keep a private log of your doses and notes for Cartalax.
Use code ANYPEPTIDES15 for 15% off your order.
Discount may end or change without notice.